Secretin Injection

[28 May 2015]

Products Affected - Description

ChiRhoStim lyophilized powder for solution for injection, ChiRhoClin
16 mcg, vial, single count (NDC 67066-0005-01)

Reason for the Shortage

  • ChiRhoClin is qualifying a manufacturing site.
  • ChiRhoClin has been working with FDA to release ChiRhoStim lot # 0636149. This lot was produced at a new manufacturing site that has not been approved by FDA. Please see the Dear Health Care Provider letter for additional information. ChiRhoClin anticipates the release of a new ChiRhoStim lot in 2015.

Available Products

ChiRhoStim produced at a new manufacturing site not yet approved by FDA is available and requires filtration.

Estimated Resupply Dates

ChiRhoClin has ChiRhoStim available. Order product through your wholesaler or by direct order.


ChiRhoStim from batch #0636149 should be filtered using a Millex-GV Syringe Microbial Filter Unit prior to administration. These microbial filters are included with each vial of ChiRhoStim.


May 28, April 3, February 9, January 12, 2015; December 15, November 5, September 10,; August 1, June 30,; June 3, March 21, February 20, January 8, 2014; December 3, November 11, October 28, September 9, August 5, July 23, May 30, April 29, March 26, February 20, February 7, January 11, 2013; November 28, October 16, September 26, August 22, July 18, June 20, May 21, and May 9, 2012; University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.